mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
5e-10 |
mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
1e-09 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
3e-08 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
6e-08 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
7e-08 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
8e-08 |
mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-07 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-07 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
2e-07 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-07 |